{"content":"<li class=\"n-box-item date-title\" data-end=\"1379476799\" data-start=\"1379390400\" data-txt=\"Friday, December 20, 2019\">Tuesday, September 17, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1285062\" data-ts=\"1379453771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1285062-after-hours-top-gainers-losers-as-of-5-15-p-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers / Losers, as of 5:15 p.m.</a></h4><ul>     <li><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a> <font color='green'>+4.6%</font>. <a href='https://seekingalpha.com/symbol/LLEN' title='L&L Energy, Inc.'>LLEN</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/DNDN' title='Dendreon Corporation'>DNDN</a> <font color='green'>+2.8%</font>. <a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Inc.'>SOHU</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a> <font color='green'>+1.8%</font>.</li><li><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/WLDN' title='Willdan Group, Inc.'>WLDN</a> <font color='red'>-4.3%</font>. <a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a> <font color='red'>-2.7%</font>. <a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/SSP' title='The E.W. Scripps Company'>SSP</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/OFG' title='OFG Bancorp'>OFG</a> <font color='red'>-1.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1285062\" data-linked=\"After-hours top gainers / Losers, as of 5:15 p.m.\" data-tweet=\"$ADBE $LLEN $DNDN - After-hours top gainers / Losers, as of 5:15 p.m. https://seekingalpha.com/news/1285062-after-hours-top-gainers-losers-as-of-5-15-p-m?source=tweet\" data-url=\"https://seekingalpha.com/news/1285062-after-hours-top-gainers-losers-as-of-5-15-p-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284982\" data-ts=\"1379451934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REPYY\" target=\"_blank\">REPYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284982-companies-mentioned-as-potential-repsol-targets-posted-gains-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Companies mentioned as potential Repsol targets posted gains today</a></h4><ul>     <li>In an apparent delayed reaction, companies mentioned as possible takeover targets for Repsol (<a href='https://seekingalpha.com/symbol/REPYY' title='Repsol S.A. ADR'>OTCQX:REPYY</a>, <a href='https://seekingalpha.com/symbol/REPYF' title='Repsol S.A.'>OTCQX:REPYF</a>) as it reportedly <a href=\"https://seekingalpha.com/currents/post/1280022\" target=\"_blank\">looks to make a North American oil acquisition</a> in the $5B-$10B range moved higher today.</li>     <li>After showing only mild action yesterday, Whiting Petroleum (<a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='green'>+3.7%</font>) and Kodiak Oil &amp;&nbsp;Gas (<a href='https://seekingalpha.com/symbol/KOG' title='Kodiak Oil & Gas Corp'>KOG</a> <font color='green'>+1.6%</font>) posted strong gains gains; strength in SandRidge Energy (<a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a> <font color='green'>+6%</font>) also may have been sparked by Respol speculation, although SD wasn't mentioned in this weekend's <em>WSJ</em> article.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284982\" data-linked=\"Companies mentioned as potential Repsol targets posted gains today\" data-tweet=\"$REPYY $REPYY $REPYF - Companies mentioned as potential Repsol targets posted gains today https://seekingalpha.com/news/1284982-companies-mentioned-as-potential-repsol-targets-posted-gains-today?source=tweet\" data-url=\"https://seekingalpha.com/news/1284982-companies-mentioned-as-potential-repsol-targets-posted-gains-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284812\" data-ts=\"1379449204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFOP\" target=\"_blank\">AFOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284812-alliance-fiber-optic-spikes-after-raising-q3-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Fiber Optic spikes after raising Q3 guidance</a></h4><ul>     <li>Shares of Alliance Fiber Optic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AFOP\" title=\"Alliance Fiber Optic Products, Inc.\">AFOP</a>) are <font color=\"green\">up 14.4%</font> AH after the company raises Q3 guidance, forecasting revenue above $22M (versus a previous $19.5M-$20.5M and consensus of $20M).</li>     <li>CEO Peter Chang: \"With increased demands for datacomm applications, customer orders have been stronger than expected,<em>[sic]</em> since the last conference call.\"</li>\n<li>The company completed a 2-for-1 split in the morning.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284812\" data-linked=\"Alliance Fiber Optic spikes after raising Q3 guidance\" data-tweet=\"$AFOP - Alliance Fiber Optic spikes after raising Q3 guidance https://seekingalpha.com/news/1284812-alliance-fiber-optic-spikes-after-raising-q3-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1284812-alliance-fiber-optic-spikes-after-raising-q3-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284772\" data-ts=\"1379448934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284772-sangamo-biosciences-to-offer-shares-stock-falls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo BioSciences to offer shares, stock falls</a></h4><ul>     <li>Sangamo BioSciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SGMO\" title=\"Sangamo Therapeutics, Inc.\">SGMO</a>) announces a planned public offering.</li>     <li>The size of the deal is not disclosed.</li>     <li>There will be a 15% underwriter option. (PR)</li>     <li>Shares <font color=\"red\">-5.4%</font> AH</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284772\" data-linked=\"Sangamo BioSciences to offer shares, stock falls\" data-tweet=\"$SGMO - Sangamo BioSciences to offer shares, stock falls https://seekingalpha.com/news/1284772-sangamo-biosciences-to-offer-shares-stock-falls?source=tweet\" data-url=\"https://seekingalpha.com/news/1284772-sangamo-biosciences-to-offer-shares-stock-falls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284662\" data-ts=\"1379447505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNDN\" target=\"_blank\">DNDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284662-needham-reiterates-dendreon-at-buy-after-eu-provenge-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham reiterates Dendreon at Buy after EU Provenge approval</a></h4><ul>\n<li>Don't tell the <a href=\"https://seekingalpha.com/currents/post/1211452\" target=\"_blank\">naysayers</a>, but European <a href=\"https://seekingalpha.com/currents/post/1283162\" target=\"_blank\">approval for Provenge</a> is \"a clear positive\" for Dendreon (<a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a> <font color=\"green\">+5.5%</font>), Needham says, <a href=\"http://www.streetinsider.com/Analyst+Comments/EU+Approval+a+%27Clear+Positive%27+for+Dendreon+%28DNDN%29+-+Needham+%26+Company/8696468.html\" target=\"_blank\">reiterating</a> a Buy rating and a $7 price target.</li>\n<li>Investors might not want to back the truck up just yet though, as analyst Chad Messer still \"expects it to take a number of quarters to see meaningful European sales.\"</li>\n<li>That said, Needham is positive on upcoming clinical data which should \"support wider and earlier use of <a href=\"https://seekingalpha.com/currents/search?query=provenge\" target=\"_blank\">Provenge</a>.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1284662\" data-linked=\"Needham reiterates Dendreon at Buy after EU Provenge approval\" data-tweet=\"$DNDN - Needham reiterates Dendreon at Buy after EU Provenge approval https://seekingalpha.com/news/1284662-needham-reiterates-dendreon-at-buy-after-eu-provenge-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/1284662-needham-reiterates-dendreon-at-buy-after-eu-provenge-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284532\" data-ts=\"1379445324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284532-as-clovis-rumor-rally-fades-ariad-tesaro-move-higher-by-association\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">As Clovis rumor rally fades, Ariad, Tesaro move higher by association</a></h4><ul>\n<li>The rally in Clovis Oncology (<a href=\"https://seekingalpha.com/symbol/CLVS\" title=\"Clovis Oncology\">CLVS</a> <font color=\"green\">+5.9%</font>)Â seems to be fading a bit after the stock jumped nearly 18% on a Bloomberg report which suggested the company may be <a href=\"https://seekingalpha.com/currents/post/1284392\" target=\"_blank\">pursuing a sale</a>.</li>\n<li>Worth watching on the news is Ariad (<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"green\">+3.6%</font>), which rallied when the story broke. ARIA's <a href=\"https://seekingalpha.com/currents/search?query=AP26113\" target=\"_blank\">AP26113</a> is       an ALK, EGFR, and ROS1 inhibitor. CLVS' lead compound CO-1686 is also an EGFR inhibitor.</li>\n<li>Likewise getting a bump around the time the news hit was Tesaro (<a href=\"https://seekingalpha.com/symbol/TSRO\" title=\"Tesaro\">TSRO</a> <font color=\"green\">+0.2%</font>), whose <a href=\"https://seekingalpha.com/currents/search?query=Niraparib\" target=\"_blank\">Niraparib</a> is (like CLVS' <a href=\"http://www.clovisoncology.com/products-companion-diagnostics/rucaparib/\" target=\"_blank\">Rucapari</a>) a PARP inhibitor.</li>\n<li>Another notable company with a PARP inhibitor: <a href=\"https://seekingalpha.com/symbol/BMRN\" title=\"BioMarin Pharmaceutical Inc.\">BMRN</a>, which is itself no stranger to acquisition rumors.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1284532\" data-linked=\"As Clovis rumor rally fades, Ariad, Tesaro move higher by association\" data-tweet=\"$CLVS $CLVS $ARIA - As Clovis rumor rally fades, Ariad, Tesaro move higher by association https://seekingalpha.com/news/1284532-as-clovis-rumor-rally-fades-ariad-tesaro-move-higher-by-association?source=tweet\" data-url=\"https://seekingalpha.com/news/1284532-as-clovis-rumor-rally-fades-ariad-tesaro-move-higher-by-association\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284492\" data-ts=\"1379444344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRE\" target=\"_blank\">GPRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284492-green-plains-minus-7_6-percent-as-it-upsizes-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Plains -7.6% as it upsizes debt offering</a></h4><ul>     <li>Green Plains Renewable Energy (<a href=\"https://seekingalpha.com/symbol/GPRE\" title=\"Green Plains Inc.\">GPRE</a> <font color=\"red\">-7.6%</font>) prices of its offering of senior notes due 2018 and boosted the size of the offering to $100M from $75M.</li>\n<li>GPRE plans to use the net proceeds for general corporate agreements but may use a portion to acquire or invest in additional facilities, assets or technologies, or retire existing debt.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284492\" data-linked=\"Green Plains -7.6% as it upsizes debt offering\" data-tweet=\"$GPRE - Green Plains -7.6% as it upsizes debt offering https://seekingalpha.com/news/1284492-green-plains-minus-7_6-percent-as-it-upsizes-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1284492-green-plains-minus-7_6-percent-as-it-upsizes-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284472\" data-ts=\"1379443897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTATQ\" target=\"_blank\">GTATQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284472-china-places-curbs-on-solar-capex-sets-investment-minimums\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China places curbs on solar capex, sets investment minimums</a></h4><ul>     <li>In an official statement (<a href=\"http://www.miit.gov.cn/n11293472/n11293832/n11293907/n11368223/15628993.html\" target=\"_blank\">translation</a>), China's industry/IT ministry <a href=\"http://www.bloomberg.com/news/2013-09-17/china-to-strictly-limit-building-of-more-photovoltaic-capacity.html\" target=\"_blank\">says it will ban</a> solar manufacturing projects that \"purely\" expand capacity. However, the ministry is also mandating a solar company's annual spending on R&amp;D and equipment upgrades combined must exceed 3% of revenue and RMB10M ($1.6M).</li>     <li>Analysts thinks the mandate is a not-so-subtle way of urging companies to merge.</li>     <li>As solar equipment suppliers such as GT Advanced (GTAT <font color=\"green\">+2.7%</font>) and Veeco (<a href=\"https://seekingalpha.com/symbol/VECO\" title=\"Veeco Instruments Inc.\">VECO</a> <font color=\"red\">-2.1%</font>) <a href=\"https://seekingalpha.com/currents/post/1194042\" target=\"_blank\">can vouch</a>, solar manufacturers (Chinese or otherwise) aren't investing much anyway, as they try to soak up the huge amounts of excess capacity created in past years.</li>     <li>The revenue and <a href=\"https://seekingalpha.com/currents/post/1233342\" target=\"_blank\">gross margin</a> figures provided in the Q2 reports of many solar names (not to mention the YTD performance of their shares) suggest decent progress is being made. Enough so that some think manufacturers will be <a href=\"https://seekingalpha.com/currents/post/1235882\" target=\"_blank\">compelled to add capacity</a> next year.</li>     <li>Most Chinese module vendors are trading lower, but not all of them: <a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"red\">-4.4%</font>. <a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a> <font color=\"red\">-3.2%</font>. <a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"red\">-2.2%</font>. <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"red\">-0.8%</font>. <a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"red\">-0.6%</font>. <a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"green\">+0.9%</font>. <a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+1%</font>. Polysilicon maker Daqo (<a href=\"https://seekingalpha.com/symbol/DQ\" title=\"DAQO New Energy Corp.\">DQ</a> <font color=\"green\">+9.9%</font>) is up strongly.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284472\" data-linked=\"China places curbs on solar capex, sets investment minimums\" data-tweet=\"$GTATQ $GTATQ $VECO - China places curbs on solar capex, sets investment minimums https://seekingalpha.com/news/1284472-china-places-curbs-on-solar-capex-sets-investment-minimums?source=tweet\" data-url=\"https://seekingalpha.com/news/1284472-china-places-curbs-on-solar-capex-sets-investment-minimums\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284462\" data-ts=\"1379443877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGR\" target=\"_blank\">RGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284462-demand-trends-in-gun-sector-up-for-debate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Demand trends in gun sector up for debate</a></h4><ul> <li>Sturm Ruger (<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a> <font color='green'>+2.4%</font>), Cabela's (<a href='https://seekingalpha.com/symbol/CAB' title='Cabela&#39;s Incorporated'>CAB</a> <font color='green'>+1.5%</font>), and Smith &amp; Wesson (SWHC <font color='green'>+2.7%</font>) trade higher after the stocks fell back in response to a mass shooting at the Washington D.C. Navy Yard yesterday.</li> <li>Some early reaction to the tragedy is <a href=\"http://www.nytimes.com/2013/09/18/us/washington-navy-yard-shootings.html\" target=\"_blank\">focused on</a> the suspect's history of mental illness, although calls for stricter gun control laws are also part of the debate.</li> <li>A broader theme in the weapons manufacturing sector is the trend toward slowing demand. Earlier this month, Smith &amp; Wesson issued guidance for Q3 revenue which fell below the consensus estimate of analysts.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284462\" data-linked=\"Demand trends in gun sector up for debate\" data-tweet=\"$RGR $RGR $CAB - Demand trends in gun sector up for debate https://seekingalpha.com/news/1284462-demand-trends-in-gun-sector-up-for-debate?source=tweet\" data-url=\"https://seekingalpha.com/news/1284462-demand-trends-in-gun-sector-up-for-debate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284412\" data-ts=\"1379442501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284412-take-two-gives-up-early-gains-in-spite-of-stellar-gta-v-reviews\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Take-Two gives up early gains in spite of stellar GTA V reviews</a></h4><ul>\n<li>Were expectations too high? Even though <em>Grand Theft Auto V</em>'s launch day has yielded plenty of <a href=\"http://ottawa.ctvnews.ca/gamers-brave-line-ups-for-grand-theft-auto-v-1.1458613\" target=\"_blank\">long lines</a> and a <a href=\"http://www.metacritic.com/game/xbox-360/grand-theft-auto-v\" target=\"_blank\">Metacritic score</a> of 98/100, Take-Two (<a href=\"https://seekingalpha.com/symbol/TTWO\" title=\"Take-Two Interactive Software, Inc.\">TTWO</a> <font color=\"red\">-2.3%</font>) has given back its <a href=\"https://seekingalpha.com/currents/post/1282882\" target=\"_blank\">premarket gains</a>, and is now down 4% over the last two days.</li>\n<li>Reviewers glow about <em>GTA V</em>'s movie-like realism, use of multiple protagonists (or are they antagonists?), and freewheeling plot lines. <a href=\"http://www.polygon.com/2013/9/16/4720458/gta-5-review-grand-theft-auto\" target=\"_blank\">Polygon:</a> \"<em>GTA V</em> is a bridge between games' present and the future.\" <a href=\"http://www.joystiq.com/2013/09/16/grand-theft-auto-5-review/\" target=\"_blank\">Joystiq:</a> \"The open-ended gameplay remains a showpiece for the vast amount of content that can be poured into a virtual world.\"</li>\n<li>Wedbush's <a href=\"http://tech.fortune.cnn.com/2013/09/17/grand-theft-auto-v/\" target=\"_blank\">Michael Pachter</a> thinks <em>GTA V</em> will see 20M-25M unit sales over its lifetime, and generate up to $1.57B in revenue for Take-Two. But as Pachter notes, Take-Two shares <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1379079000000&amp;chddm=71212&amp;chls=IntervalBasedLine&amp;q=NASDAQ:TTWO&amp;ntsp=1&amp;ei=nZw4UrjVFcW5iwL2twE\" target=\"_blank\">have already priced in</a> a lot of good news.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1284412\" data-linked=\"Take-Two gives up early gains in spite of stellar GTA V reviews\" data-tweet=\"$TTWO - Take-Two gives up early gains in spite of stellar GTA V reviews https://seekingalpha.com/news/1284412-take-two-gives-up-early-gains-in-spite-of-stellar-gta-v-reviews?source=tweet\" data-url=\"https://seekingalpha.com/news/1284412-take-two-gives-up-early-gains-in-spite-of-stellar-gta-v-reviews\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284392\" data-ts=\"1379441718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284392-clovis-oncology-evaluating-possible-sale-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clovis Oncology evaluating possible sale: Bloomberg</a></h4><ul><li>Shares of Clovis Oncology (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='green'>+13.1%</font>) spike midday on reports the company may be <a href=\"http://www.bloomberg.com/news/2013-09-17/clovis-oncology-said-to-explore-sale-of-biotech-company.html\" target=\"_blank\">exploring a sale</a>.</li><li>Credit Suisse is advising the company on its options, Bloomberg says, citing sources.</li></ul><div class=\"tiny-share-widget\" data-id=\"1284392\" data-linked=\"Clovis Oncology evaluating possible sale: Bloomberg\" data-tweet=\"$CLVS - Clovis Oncology evaluating possible sale: Bloomberg https://seekingalpha.com/news/1284392-clovis-oncology-evaluating-possible-sale-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/1284392-clovis-oncology-evaluating-possible-sale-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284382\" data-ts=\"1379441524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BERY\" target=\"_blank\">BERY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284382-berry-plastics-tumbles-on-reduced-q4-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Berry Plastics tumbles on reduced Q4 outlook</a></h4><ul>\n<li>Shares of Berry Plastics (<a href=\"https://seekingalpha.com/symbol/BERY\" title=\"Berry Plastics Group, Inc.\">BERY</a> <font color=\"red\">-12.5%</font>) tumble after the company slashes its Q4 EBITDA guidance to -10% of Q4 EBITDA from a <a href=\"https://seekingalpha.com/article/1599162-berry-plastics-group-management-discusses-q3-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">previously forecast</a> \"modest increase\" at its investor day.</li>\n<li>The company also stated it will pursue \"all avenues\" for returning value to shareholders.</li>\n<li>RW Baird believes BERY shares are likely to remain range-bound due to the guidance cut. Baird previously stated that the investor day would be a net positive for the stock.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1284382\" data-linked=\"Berry Plastics tumbles on reduced Q4 outlook\" data-tweet=\"$BERY - Berry Plastics tumbles on reduced Q4 outlook https://seekingalpha.com/news/1284382-berry-plastics-tumbles-on-reduced-q4-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/1284382-berry-plastics-tumbles-on-reduced-q4-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284372\" data-ts=\"1379441491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQT\" target=\"_blank\">EQT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284372-in-energy-milestone-eqt-in-first-ever-fracking-job-powered-only-by-well-gas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In energy milestone, EQT in first-ever fracking job powered only by well gas</a></h4><ul>     <li>EQT Corp. (<a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a> <font color='green'>+1.5%</font>) and Green Field Energy say they completed the first fracking job <a href=\"http://www.examiner.com/article/eqt-and-green-field-set-industry-milestone-for-hydraulic-fracturing\" target=\"_blank\">powered solely by natural gas tapped from a nearby well</a>, using well gas to complete jobs on a Marcellus shale well in Pennsylvania.</li>     <li>Some operators, including Apache (NYSE:<a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a>), have estimated that using well gas <a href=\"http://fuelfix.com/blog/2013/09/17/companies-power-fracturing-job-with-field-gas\" target=\"_blank\">could cut fuel costs by 70%</a>; APA has said that if all fracking jobs switched to well gas, energy companies could cut their industry-wide fuel costs by $1.67B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284372\" data-linked=\"In energy milestone, EQT in first-ever fracking job powered only by well gas\" data-tweet=\"$EQT $EQT $APA - In energy milestone, EQT in first-ever fracking job powered only by well gas https://seekingalpha.com/news/1284372-in-energy-milestone-eqt-in-first-ever-fracking-job-powered-only-by-well-gas?source=tweet\" data-url=\"https://seekingalpha.com/news/1284372-in-energy-milestone-eqt-in-first-ever-fracking-job-powered-only-by-well-gas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284332\" data-ts=\"1379440034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284332-repros-therapeutics-not-so-fast-says-feuerstein\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Repros Therapeutics: Not so fast, says Feuerstein</a></h4><ul>\n<li>One of today's big movers is Repros Therapeutics (<a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"green\">+11.3%</font>), as <a href=\"https://seekingalpha.com/currents/post/1283032\" target=\"_blank\">fresh data on Androxal</a> has the stock on a tear.</li>\n<li>If you follow healthcare stocks closely, you know you can often look for the bear thesis from <em>theStreet</em>'s Adam Feuerstein \u2014 today's RPRX rally is no exception.</li>\n<li>Among the things Feuerstein <a href=\"http://www.thestreet.com/story/12040051/1/why-repros-is-still-a-risky-stock-despite-stocks-ascent.html\" target=\"_blank\">wants to know</a>: 1) \"What was the rate of testosterone normalization for men treated with placebo?\" 2) \"What were the baseline and end-of-treatment levels of testosterone for patients in both arms of the study?\", and 3) \"Was the testosterone normalization endpoint reached with statistical significance?\"</li>\n<li>Other concerns include an apparently non-committal stance on whether the sperm-count endpoint was met and the prospect of a \"messy challenge\" to Androxal's patents (more on this <a href=\"https://seekingalpha.com/currents/post/1193212\" target=\"_blank\">here</a>).</li>\n<li>Companies who market \"low T\" treatments include <a href=\"https://seekingalpha.com/symbol/ABBV\" title=\"AbbVie Inc.\">ABBV</a>, <a href=\"https://seekingalpha.com/symbol/AUXL\" title=\"Auxilium Pharmaceuticals, Inc.\">AUXL</a>, and <a href=\"https://seekingalpha.com/symbol/LLY\" title=\"Eli Lilly and Company\">LLY</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1284332\" data-linked=\"Repros Therapeutics: Not so fast, says Feuerstein\" data-tweet=\"$RPRX $RPRX $ABBV - Repros Therapeutics: Not so fast, says Feuerstein https://seekingalpha.com/news/1284332-repros-therapeutics-not-so-fast-says-feuerstein?source=tweet\" data-url=\"https://seekingalpha.com/news/1284332-repros-therapeutics-not-so-fast-says-feuerstein\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284302\" data-ts=\"1379439305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PERI\" target=\"_blank\">PERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284302-perion-network-climbs-on-benchmark-pt-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perion Network climbs on Benchmark PT hike</a></h4><ul><li>Shares of Perion Network (<a href='https://seekingalpha.com/symbol/PERI' title='Perion Network Ltd.'>PERI</a> <font color='green'>+5.8%</font>) climb after Benchmark<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/09/3919250/update-benchmark-company-reiterates-on-perion-network-lt\" target=\"_blank\"> hikes</a> its PT to $19 from $16 and reiterates a Buy rating.</li><li>The firm is bullish on<a href=\"https://seekingalpha.com/currents/post/1280902\" target=\"_blank\"> Perion's reverse merger </a>with Conduit's toolbar unit: \"We view the transaction as a significant positive for Perion, giving the company instant scale at a sub-market purchase multiple of 5.5x 2014E EV/EBITDA assuming what we believe is a conservative outlook for Conduit, including no benefit from cost synergies or leverage from existing distribution relationships.\"</li><li>SA contributor&nbsp;Igor Novgorodtsev <a href=\"https://seekingalpha.com/article/1697792-perion-and-conduit-match-made-in-heaven?source=yahoo\" target=\"_blank\">believes</a> the merger will capitalize on business synergies and complementary business models.</li></ul><div class=\"tiny-share-widget\" data-id=\"1284302\" data-linked=\"Perion Network climbs on Benchmark PT hike\" data-tweet=\"$PERI - Perion Network climbs on Benchmark PT hike https://seekingalpha.com/news/1284302-perion-network-climbs-on-benchmark-pt-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/1284302-perion-network-climbs-on-benchmark-pt-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284202\" data-ts=\"1379436403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284202-midday-top-10-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers / Losers</a></h4><ul>     <li>\n<b>Midday top 10 gainers:</b> AFFM.OB <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/KYTH\" title=\"KYTHERA Biopharmaceuticals\">KYTH</a> <font color=\"green\">+27%</font>. <a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/AGEN\" title=\"Agenus\">AGEN</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/ARO\" title=\"Aeropostale, Inc.\">ARO</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/IGLD\" title=\"Internet Gold Golden Lines Ltd.\">IGLD</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/BCOM\" title=\"B Communications Ltd.\">BCOM</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/HZNP\" title=\"Horizon Pharma plc\">HZNP</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/TRX\" title=\"Tanzanian Royalty Exploration Corp.\">TRX</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/IDRA\" title=\"Idera Pharmaceuticals, Inc.\">IDRA</a> <font color=\"green\">+11%</font>.</li>\n<li>\n<b>Midday top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/GORO\" title=\"Gold Resource Corporation\">GORO</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/CVT\" title=\"Cvent, Inc.\">CVT</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/FFHL\" title=\"Fuwei Films (Holdings) Co., Ltd.\">FFHL</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/OUTR\" title=\"Outerwall Inc.\">OUTR</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/CRDS\" title=\"Crossroads Systems, Inc.\">CRDS</a> <font color=\"red\">-11%</font>. IDI <font color=\"red\">-11%</font>. RECV <font color=\"red\">-10%</font>. FMAR.OB <font color=\"red\">-10%</font>. XNY <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/RCG\" title=\"RENN Global Entrepreneurs Fund\">RCG</a> <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284202\" data-linked=\"Midday top 10 gainers / Losers\" data-tweet=\"$AFFMQ $KYTH $RPRX - Midday top 10 gainers / Losers https://seekingalpha.com/news/1284202-midday-top-10-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1284202-midday-top-10-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284182\" data-ts=\"1379435957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOHU\" target=\"_blank\">SOHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284182-sohu-gives-up-early-gains-wedge-critical-of-tencent-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sohu gives up early gains, Wedge critical of Tencent dividend</a></h4><ul>     <li>After opening higher thanks to <a href=\"https://seekingalpha.com/currents/post/1282952\" target=\"_blank\">Goldman's upgrade</a>, Sohu (<a href=\"https://seekingalpha.com/symbol/SOHU\" title=\"Sohu.com Limited\">SOHU</a> <font color=\"red\">-1.1%</font>) has turned negative following a <a href=\"https://twitter.com/thenotablecalls/status/379976868683739136\" target=\"_blank\">Wedge Partners note</a> that observes the company's Sogou search unit will use $301M of the <a href=\"https://seekingalpha.com/currents/post/1280552\" target=\"_blank\">$448M investment</a> it will receive from Tencent to pay a special dividend to owners of Sogou's Series A preferred stock (as disclosed in a <a href=\"http://biz.yahoo.com/e/130916/sohu8-k.html\" target=\"_blank\">Sohu 8-K</a>).</li>     <li>\n<a href=\"https://twitter.com/thenotablecalls/status/379976618992607232\" target=\"_blank\">Wedge declares</a> the dividend payment to be an example of insider highway robbery.</li>     <li>Shares still <font color=\"green\">+6%</font> from where they traded before the Tencent announcement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284182\" data-linked=\"Sohu gives up early gains, Wedge critical of Tencent dividend\" data-tweet=\"$SOHU - Sohu gives up early gains, Wedge critical of Tencent dividend https://seekingalpha.com/news/1284182-sohu-gives-up-early-gains-wedge-critical-of-tencent-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/1284182-sohu-gives-up-early-gains-wedge-critical-of-tencent-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284162\" data-ts=\"1379435741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUN\" target=\"_blank\">HUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284162-huntsman-higher-after-rockwood-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huntsman higher after Rockwood purchase</a></h4><ul>     <li>Huntsman (<a href=\"https://seekingalpha.com/symbol/HUN\" title=\"Huntsman Corporation\">HUN</a> <font color=\"green\">+2.8%</font>) is higher after the chemicals maker <a href=\"https://seekingalpha.com/currents/post/1282702\" target=\"_blank\">agreed to buy</a> Rockwood Holdings' (<a href=\"https://seekingalpha.com/symbol/ROC\" title=\"Rockwood Holdings, Inc.\">ROC</a> <font color=\"green\">+1.2%</font>) performance additives and titanium dioxide businesses for $1.1B.</li>     <li>The deal allows HUN to become the second largest global producer (behind DuPont) of titanium dioxide and inorganic color pigments for uses such as paints and industrial coatings.</li>\n<li>The chemicals industry is emerging from a trough in production and profit, but now <a href=\"http://fuelfix.com/blog/2013/09/17/huntsman-to-buy-rockwood-businesses-for-1-1b\" target=\"_blank\">things are looking up</a>, and HUN\u2019s estimate on the titanium  dioxide assets\u2019 earnings - $200M in 2014 - seems reasonable, an Alembic Global analyst says.</li>\n<li>\"There\u2019s a case to be made that they\u2019re not leveraging up for this,\u201d the analyst says; HUN's debt sits above industry norms at ~3.5x EBITDA, but it could bundle its new debt into the pigments assets spinoff when it goes  public.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284162\" data-linked=\"Huntsman higher after Rockwood purchase\" data-tweet=\"$HUN $HUN $ROC - Huntsman higher after Rockwood purchase https://seekingalpha.com/news/1284162-huntsman-higher-after-rockwood-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/1284162-huntsman-higher-after-rockwood-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284122\" data-ts=\"1379434772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPP-OLD\" target=\"_blank\">WPP-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284122-starboard-stirs-up-interest-in-wausau-paper-with-a-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starboard stirs up interest in Wausau Paper with a mention</a></h4><ul> <li>Wausau Paper (<a href='https://seekingalpha.com/symbol/WPP-OLD' title='Wausau Paper Corp.'>WPP-OLD</a> <font color='green'>+0.2%</font>) shoots higher from negative territory after Starboard Value <a href=\"https://twitter.com/kajawhitehouse/status/380001066042929152\" target=\"_blank\">calls</a> the company's tissue business a \"gem\" at an investor conference.</li> <li>Starboard's Jeff Smith is still on the mike and shares of WPP are still on the move.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1284122\" data-linked=\"Starboard stirs up interest in Wausau Paper with a mention\" data-tweet=\"$WPP-OLD - Starboard stirs up interest in Wausau Paper with a mention https://seekingalpha.com/news/1284122-starboard-stirs-up-interest-in-wausau-paper-with-a-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/1284122-starboard-stirs-up-interest-in-wausau-paper-with-a-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284052\" data-ts=\"1379433592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284052-russia-to-cut-oil-flow-to-belarus-by-42-percent-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Russia to cut oil flow to Belarus by 42% in Q4</a></h4><ul>     <li>Russia continues to <a href=\"http://www.reuters.com/article/2013/09/17/russia-belarus-oil-idUSL5N0HD17J20130917\" target=\"_blank\">ratchet up the pressure</a> on Belarus amid the potash spat, as an export schedule shows it will cut oil pipeline supplies to the country by 42% in Q4.</li>     <li>According to the schedule, Russia will ship 3.1M metric tons of oil (62K bbl/day) to refineries in Belarus via pipeline in October-December, down from 5.3M metric tons originally planned for Q3.</li>     <li>Russian oil pipeline monopoly Transneft also has said oil shipments to Belarus would be cut by 233K metric tons in September due to pipeline repairs.</li>     <li>POT <font color=\"red\">-1.8%</font>, <a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"red\">-0.8%</font>, AGU <font color=\"red\">-1.4%</font>, <a href=\"https://seekingalpha.com/symbol/IPI\" title=\"Intrepid Potash, Inc.\">IPI</a> <font color=\"red\">-1%</font>, <a href=\"https://seekingalpha.com/symbol/SQM\" title=\"Chemical &amp; Mining Co. of Chile Inc.\">SQM</a> <font color=\"red\">-0.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284052\" data-linked=\"Russia to cut oil flow to Belarus by 42% in Q4\" data-tweet=\"$NTR $NTR $MOS - Russia to cut oil flow to Belarus by 42% in Q4 https://seekingalpha.com/news/1284052-russia-to-cut-oil-flow-to-belarus-by-42-percent-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/1284052-russia-to-cut-oil-flow-to-belarus-by-42-percent-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1284002\" data-ts=\"1379433157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1284002-susquehanna-bullish-on-broadcom-due-to-iphone-6-apple-suppliers-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna bullish on Broadcom due to iPhone 6; Apple suppliers up</a></h4><ul>     <li>Discussing his <a href=\"https://seekingalpha.com/currents/post/1283512\" target=\"_blank\">upgrade</a> of Broadcom (BRCM <font color=\"green\">+2.6%</font>) to Positive, Susquehanna's <a href=\"http://blogs.barrons.com/techtraderdaily/2013/09/17/this-morning-microsoft-pays-up-triangulating-iphone-orders-cheers-for-cavm-brcm/\" target=\"_blank\">Chris Caso</a> declares expectations have been reset thanks to a <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1379079000000&amp;chddm=16770&amp;chls=IntervalBasedLine&amp;q=NASDAQ:BRCM&amp;ntsp=1&amp;ei=sHg4UpDIAuSyiALKUw\" target=\"_blank\">summer swoon</a>, and that an iPhone 6 launch (expected in Q2 '14) will <a href=\"https://twitter.com/thenotablecalls/status/379954106309173248\" target=\"_blank\">act as a catalyst</a>.</li>     <li>Caso also views improving networking chip demand and <a href=\"https://seekingalpha.com/currents/post/1260562\" target=\"_blank\">the purchase</a> of Renesas' 4G baseband chip unit as reasons to be bullish.</li>     <li>Some other Apple suppliers are also rallying today: <a href=\"https://seekingalpha.com/symbol/CRUS\" title=\"Cirrus Logic, Inc.\">CRUS</a> <font color=\"green\">+2.8%</font>. <a href=\"https://seekingalpha.com/symbol/SWKS\" title=\"Skyworks Solutions, Inc.\">SWKS</a> <font color=\"green\">+1.5%</font>. NTE <font color=\"green\">+2%</font>. Avago is up after catching an upgrade to Outperform from JMP.</li>     <li>The iPhone 6 is <a href=\"http://www.usdailyvoice.com/kgi-securities-kuo-expects-4-5-to-5-inch-display-for-iphone-6-15989/gloriaacosta.html\" target=\"_blank\">widely expected</a> to feature a larger display, something considered necessary to slow international share losses as demand for large-screen Android phones <a href=\"https://seekingalpha.com/currents/post/1254152\" target=\"_blank\">takes off</a>. Two weeks ago, <a href=\"https://seekingalpha.com/currents/post/1263812\" target=\"_blank\">the <em>WSJ</em> reported </a>Apple is thinking of offering \"iPhones with screens ranging from 4.8 inches to as high as six inches.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1284002\" data-linked=\"Susquehanna bullish on Broadcom due to iPhone 6; Apple suppliers up\" data-tweet=\"$AVGO $AVGO $CRUS - Susquehanna bullish on Broadcom due to iPhone 6; Apple suppliers up https://seekingalpha.com/news/1284002-susquehanna-bullish-on-broadcom-due-to-iphone-6-apple-suppliers-up?source=tweet\" data-url=\"https://seekingalpha.com/news/1284002-susquehanna-bullish-on-broadcom-due-to-iphone-6-apple-suppliers-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283932\" data-ts=\"1379431842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283932-herbalife-hits-new-highs-as-da-davidson-suggests-buyback-may-be-close\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herbalife hits new highs as DA Davidson suggests buyback may be close</a></h4><ul>\n<li>Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"green\">+3.2%</font>) surges to a fresh 52-week high.</li>\n<li>The catalyst: Recycled <a href=\"https://twitter.com/davidfaber/status/379985223242358784\" target=\"_blank\">chatter</a> regarding a leveraged share buyback.</li>\n<li>The call looks to have emanated from a familiar place, as multiple sources are <a href=\"https://twitter.com/herbgreenberg/status/379968677971378176\" target=\"_blank\">attributing</a> it to DA Davidson's Tim Ramey.</li>\n<li>Summing up the story: KPMG's \"troubles\" earlier this year might have delayed an HLF buyback which may now be back on the table once PwC signs-off on the company's financials.</li>\n<li>Ramey <a href=\"https://seekingalpha.com/currents/post/1267162\" target=\"_blank\">suggested recently</a> that HLF may be due for a settlement for the trouble KPMG caused, while Ackman is of course <a href=\"https://seekingalpha.com/currents/post/1274052\" target=\"_blank\">putting pressure</a> on PwC.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283932\" data-linked=\"Herbalife hits new highs as DA Davidson suggests buyback may be close\" data-tweet=\"$HLF - Herbalife hits new highs as DA Davidson suggests buyback may be close https://seekingalpha.com/news/1283932-herbalife-hits-new-highs-as-da-davidson-suggests-buyback-may-be-close?source=tweet\" data-url=\"https://seekingalpha.com/news/1283932-herbalife-hits-new-highs-as-da-davidson-suggests-buyback-may-be-close\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283902\" data-ts=\"1379431332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNE\" target=\"_blank\">CLNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283902-clean-energy-fuels-plus-5_3-percent-after-ceo-buys-127k-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clean Energy Fuels +5.3% after CEO buys 127K shares</a></h4><ul>     <li>Clean Energy Fuels (<a href='https://seekingalpha.com/symbol/CLNE' title='Clean Energy Fuels Corp.'>CLNE</a> <font color='green'>+5.3%</font>) powers higher after a disclosure that CEO Andrew Littlefair <a href=\"http://www.sec.gov/Archives/edgar/data/1368265/000117911013014219/xslF345X01/edgar.xml\" target=\"_blank\">acquired 127K shares</a> of the company&rsquo;s stock last Thursday at  an average $12.69/share, with a total value of ~$1.6M.</li>     <li>Following the transaction, the CEO now directly owns ~477K CLNE shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283902\" data-linked=\"Clean Energy Fuels +5.3% after CEO buys 127K shares\" data-tweet=\"$CLNE - Clean Energy Fuels +5.3% after CEO buys 127K shares https://seekingalpha.com/news/1283902-clean-energy-fuels-plus-5_3-percent-after-ceo-buys-127k-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/1283902-clean-energy-fuels-plus-5_3-percent-after-ceo-buys-127k-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283882\" data-ts=\"1379431026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LZB\" target=\"_blank\">LZB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283882-furniture-stocks-on-the-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Furniture stocks on the move</a></h4><ul>     <li>Select furniture stocks show strength after a report on <a href=\"https://seekingalpha.com/currents/post/1282832\" target=\"_blank\">chain store sales</a> and other economic reports help to lift sentiment on demand in the sub-sector.</li>     <li>Advancers: <a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/ETH' title='Ethan Allen Interiors Inc.'>ETH</a> <font color='green'>+2.2%</font>, <a href='https://seekingalpha.com/symbol/HVT' title='Haverty Furniture Companies Inc.'>HVT</a> <font color='green'>+1.5%</font>, <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='green'>+1.7%</font>, <a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='green'>+1.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283882\" data-linked=\"Furniture stocks on the move\" data-tweet=\"$LZB $LZB $ETH - Furniture stocks on the move https://seekingalpha.com/news/1283882-furniture-stocks-on-the-move?source=tweet\" data-url=\"https://seekingalpha.com/news/1283882-furniture-stocks-on-the-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283802\" data-ts=\"1379429697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRWD\" target=\"_blank\">IRWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283802-goldman-starts-ironwood-at-sell-sees-linzess-consensus-coming-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman starts Ironwood at Sell, sees Linzess consensus coming down</a></h4><ul>\n<li>Goldman becomes the second firm in a week to suggest estimates for Ironwood's (<a href=\"https://seekingalpha.com/symbol/IRWD\" title=\"Ironwood Pharmaceuticals, Inc.\">IRWD</a> <font color=\"red\">-1.2%</font>) Linzess may be too high. (see Mizuho <a href=\"https://seekingalpha.com/currents/post/1273582\" target=\"_blank\">slashes</a> Linzess revenue target)</li>\n<li>\"Linzess has a very strong profile [but] based on a physician survey we believe consensus expectations are <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Starts+Ironwood+Pharmaceuticals+%28IRWD%29+at+Sell/8694094.html\" target=\"_blank\">too aggressive</a> and will likely have to come down over time,\" Goldman says, initiating IRWD at Sell.</li>\n<li>The firm also says IRWD exhibits \"high spending levels and significant cash burn [which could lead to] profitability getting pushed out and the possibility for additional financing required in 1-2 years.\"</li>\n<li>Price target is $9.50.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283802\" data-linked=\"Goldman starts Ironwood at Sell, sees Linzess consensus coming down\" data-tweet=\"$IRWD - Goldman starts Ironwood at Sell, sees Linzess consensus coming down https://seekingalpha.com/news/1283802-goldman-starts-ironwood-at-sell-sees-linzess-consensus-coming-down?source=tweet\" data-url=\"https://seekingalpha.com/news/1283802-goldman-starts-ironwood-at-sell-sees-linzess-consensus-coming-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283742\" data-ts=\"1379428583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283742-molycorp-moves-up-on-report-china-will-add-to-rare-earth-reserves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp moves up on report China will add to rare earth reserves</a></h4><ul>     <li>Molycorp (MCP <font color=\"green\">+4.8%</font>) is on the move based on a report that <a href=\"http://www.metal.com/newscontent/53058_rare-earth-prices-to-rise-if-rumor-true-that-srb-may-buy-rare-earth-soon\" target=\"_blank\">China plans to accumulate rare earth reserves</a>; the story is dated yesterday but apparently is making the rounds today.</li>     <li>Also: <a href=\"https://seekingalpha.com/symbol/REE\" title=\"Rare Element Resources Ltd.\">REE</a> <font color=\"red\">-0.3%</font>, <a href=\"https://seekingalpha.com/symbol/AVL\" title=\"Avalon Rare Metals Inc.\">AVL</a> <font color=\"green\">+3.4%</font>, <a href=\"https://seekingalpha.com/symbol/QRM\" title=\"Quest Rare Minerals Ltd.\">QRM</a> <font color=\"green\">+3.9%</font>.</li>     <li>ETF:Â <a href=\"https://seekingalpha.com/symbol/REMX\" title=\"VanEck Vectors Rare Earth/Strategic Metals ETF\">REMX</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283742\" data-linked=\"Molycorp moves up on report China will add to rare earth reserves\" data-tweet=\"$MCPIQ $MCPIQ $REE - Molycorp moves up on report China will add to rare earth reserves https://seekingalpha.com/news/1283742-molycorp-moves-up-on-report-china-will-add-to-rare-earth-reserves?source=tweet\" data-url=\"https://seekingalpha.com/news/1283742-molycorp-moves-up-on-report-china-will-add-to-rare-earth-reserves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283732\" data-ts=\"1379428550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUXL\" target=\"_blank\">AUXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283732-goldman-makes-bullish-calls-on-auxilium-jazz-valeant-endo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman makes bullish calls on Auxilium, Jazz, Valeant, Endo</a></h4><ul>\n<li>Goldman is out resuming and starting coverage on a bevy of healthcare names. Here are the bullish calls.</li>\n<li>Auxilium Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AUXL\" title=\"Auxilium Pharmaceuticals, Inc.\">AUXL</a> <font color=\"green\">+2.9%</font>) <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Starts+Auxilium+Pharmaceuticals+%28AUXL%29+at+Buy/8694078.html\" target=\"_blank\">started at Buy</a> (price target $23) as \"very positive feedback from urologists [makes the firm] more comfortable that [AUXL] will be a <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Starts+Auxilium+Pharmaceuticals+%28AUXL%29+at+Buy/8694078.html\" target=\"_blank\">solid growth story</a> over the next several years.\" (see recent <a href=\"https://seekingalpha.com/currents/search?query=Xiaflex\" target=\"_blank\">Xiaflex</a> coverage)<br>\n</li>\n<li>Endo Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ENDP\" title=\"Endo International plc\">ENDP</a> <font color=\"green\">+0.7%</font>) <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Resumes+Endo+Pharmaceuticals+%28ENDP%29+at+Buy/8694081.html\" target=\"_blank\">resumed at Buy</a> (price target $52) as new CEO Rajiv De Silva \"has a strong track record of delivering value to shareholders.\" (see coverage of <a href=\"https://seekingalpha.com/currents/post/1067171\" target=\"_blank\">shareholder value initiatives</a>/ <a href=\"https://seekingalpha.com/currents/search?query=endo+restructuring\" target=\"_blank\">restructuring</a>)</li>\n<li>Jazz Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a> <font color=\"green\">+0.9%</font>) <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Starts+Jazz+Pharmaceuticals+%28JAZZ%29+at+Buy%3B++Attractive+Acquisition+Target/8694119.html\" target=\"_blank\">initiated at Buy</a> (price target $105) as the company's focus on \"niche specialty areas that require limited investment, have significant  pricing flexibility and have substantial barriers to entry\" is underappreciated. Also, Goldman thinks JAZZ is an \"attractive acquisition candidate.\" (see coverage on <a href=\"https://seekingalpha.com/currents/post/1193132\" target=\"_blank\">Irish domiciled takeout chatter</a>)</li>\n<li>Valeant Pharmaceuticals (VRX <font color=\"green\">+1.2%</font>) resumed at <em>Conviction Buy </em>(price target $130) as investors \"have not fully recognized the incremental value from its recent strategic <a href=\"https://seekingalpha.com/currents/search?query=bausch+valeant\" target=\"_blank\">acquisition of Bausch &amp; Lomb</a>.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283732\" data-linked=\"Goldman makes bullish calls on Auxilium, Jazz, Valeant, Endo\" data-tweet=\"$AUXL $AUXL $ENDP - Goldman makes bullish calls on Auxilium, Jazz, Valeant, Endo https://seekingalpha.com/news/1283732-goldman-makes-bullish-calls-on-auxilium-jazz-valeant-endo?source=tweet\" data-url=\"https://seekingalpha.com/news/1283732-goldman-makes-bullish-calls-on-auxilium-jazz-valeant-endo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283712\" data-ts=\"1379428374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FU\" target=\"_blank\">FU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283712-fab-universal-climbs-on-music-content-distribution-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fab Universal climbs on music content distribution deals</a></h4><ul>\n<li>Shares of Fab Universal (<a href=\"https://seekingalpha.com/symbol/FU\" title=\"FAB Universal Corp.\">FU</a> <font color=\"green\">+6.5%</font>) climb after the company secures distribution agreements for its digital music content from China Unicom, China Mobile, and China Telecom.</li>\n<li>CEO Chris Spencer believes adding a mobile content channel will allow Fab to leverage its entertainment content and reach new customers.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283712\" data-linked=\"Fab Universal climbs on music content distribution deals\" data-tweet=\"$FU - Fab Universal climbs on music content distribution deals https://seekingalpha.com/news/1283712-fab-universal-climbs-on-music-content-distribution-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/1283712-fab-universal-climbs-on-music-content-distribution-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283692\" data-ts=\"1379427893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECTYQ\" target=\"_blank\">ECTYQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283692-ecotality-files-for-chapter-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ECOtality files for Chapter 11</a></h4><ul>   <li>Electric car-charging company ECOtality (ECTY) has filed for bankruptcy protection, sending its shares <font color=\"red\">plummeting 28.4%</font>.</li>    <li>Nissan (<a href=\"https://seekingalpha.com/symbol/NSANY\" title=\"Nissan Motor Co., Ltd. ADR\">OTCPK:NSANY</a>) has agreed to provide a term loan of up to $1.25M at interest of 5% a year.</li>    <li>ECOtality plans to use the money to operate until its assets have been sold in a bankruptcy auction.</li>    <li>The Chapter 11 filing comes after ECOtality defaulted on a 2015 convertible loan.</li>    <li>The bankruptcy is likely to stoke controversy given that ECOtality has received <a href=\"http://azstarnet.com/business/local/ex-arizona-company-ecotality-near-collapse/article_f9f35661-5d81-5786-9252-d3fc51cd9198.html\" target=\"_blank\">$96M of a $115M</a> stimulus grant. (<a href=\"http://ih.advfn.com/p.php?pid=nmona&amp;article=59244504&amp;xref=newsalerttweet\" target=\"_blank\">8-K</a>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283692\" data-linked=\"ECOtality files for Chapter 11\" data-tweet=\"$ECTYQ $ECTYQ $NSANY - ECOtality files for Chapter 11 https://seekingalpha.com/news/1283692-ecotality-files-for-chapter-11?source=tweet\" data-url=\"https://seekingalpha.com/news/1283692-ecotality-files-for-chapter-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283672\" data-ts=\"1379427769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283672-3d-printing-stocks-trade-higher-following-cs-coverage-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D printing stocks trade higher following CS coverage launch</a></h4><ul>\n<li>In addition to 3D Systems (<a href=\"https://seekingalpha.com/currents/post/1283512\" target=\"_blank\">previous</a>), Stratasys (<a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a> <font color=\"green\">+3%</font>) and ExOne (<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a> <font color=\"green\">+2.3%</font>) are rallying in response to Credit Suisse's coverage launch for the industry. The gains come even though Stratasys has been started at Neutral, and ExOne at Underperform.</li>\n<li>Industrial measurement/inspection hardware vendor Perceptron (<a href=\"https://seekingalpha.com/symbol/PRCP\" title=\"Perceptron, Inc.\">PRCP</a> <font color=\"green\">+2.4%</font>), whose status as a 3D printing play has been debated (the company sells <a href=\"http://www.perceptron.com/index.php/en/-industrial/3d-scanning-solutions-g.html\" target=\"_blank\">3D scanning tools</a>, but also many other products), is also higher.</li>\n<li>Stratasys and (especially) ExOne <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1379448000000&amp;chddm=7078&amp;chls=IntervalBasedLine&amp;cmpto=NASDAQ:SSYS&amp;cmptdms=0&amp;q=NASDAQ:XONE&amp;ntsp=1&amp;ei=Y2U4UsjNCK60iALSBQ\" target=\"_blank\">have sold off</a> in September.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283672\" data-linked=\"3D printing stocks trade higher following CS coverage launch\" data-tweet=\"$SSYS $SSYS $XONE - 3D printing stocks trade higher following CS coverage launch https://seekingalpha.com/news/1283672-3d-printing-stocks-trade-higher-following-cs-coverage-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/1283672-3d-printing-stocks-trade-higher-following-cs-coverage-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283632\" data-ts=\"1379426882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TBRA\" target=\"_blank\">TBRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283632-regado-biosciences-rallies-again-after-enrolling-first-patient-in-phase-3-reg1-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regado Biosciences rallies again after enrolling first patient in Phase 3 REG1 trial</a></h4><ul>\n<li>Regado Biosciences (RGDO <font color=\"green\">+18%</font>) adds to Monday's analyst <a href=\"https://seekingalpha.com/currents/post/1280812\" target=\"_blank\">coverage-fueled gains</a>.<br>\n</li>\n<li>Earlier today, the company announced the enrollment of the first subject in a Phase 3 trial of REG1 in \"patients undergoing percutaneous coronary intervention electively  or for the treatment of unstable angina or non-ST elevated  myocardial infarction.\" (PR)</li>\n<li>Make no mistake, this is a big deal for RGDO, which <a href=\"http://www.nasdaq.com/article/regado-biosciences-prices-ipo-at-4-below-revised-5-price-cm269530\" target=\"_blank\">priced its IPO</a> at $4 last month after initially filing to sell shares at $14-16 \u2014 \"If I knew why we missed we'd have hit the target goal,\" CEO David Mazzo tells <em>FierceBiotech</em>.</li>\n<li>The IPO did give the company enough money (when combined with an earlier funding round) to get REG1 to an interim analysis, John Carroll says. From there, the hope is that \"wary investors <a href=\"http://www.fiercebiotech.com/story/regado-ceo-moves-goal-line-after-rare-biotech-ipo-misfire/2013-09-17\" target=\"_blank\">will jump into the game</a> in a big way.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283632\" data-linked=\"Regado Biosciences rallies again after enrolling first patient in Phase 3 REG1 trial\" data-tweet=\"$TBRA - Regado Biosciences rallies again after enrolling first patient in Phase 3 REG1 trial https://seekingalpha.com/news/1283632-regado-biosciences-rallies-again-after-enrolling-first-patient-in-phase-3-reg1-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/1283632-regado-biosciences-rallies-again-after-enrolling-first-patient-in-phase-3-reg1-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283572\" data-ts=\"1379426431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283572-sanofi-cvrs-boosted-by-lemtrada-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanofi CVRs boosted by Lemtrada approval</a></h4><ul>     <li>Rising along with Sanofi (<a href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\">SNY</a> <font color=\"green\">+2%</font>) after the European Commission<a href=\"https://seekingalpha.com/currents/post/1282862\" target=\"_blank\"> approves Lemtrada</a> for treatment of multiple sclerosis are the CVRs ((<a href=\"http://finance.yahoo.com/q?s=GCVRZ&amp;ql=1\" target=\"_blank\">GCVRZ</a>)) on the drug issued to Genzyme shareholders upon its sale to Sanofi.</li>     <li>These rights offer a $1 payout to their owners upon approval by the FDA, and then milestone payments based on sales targets. Purchase of the CVRs was one of SA Pro's Chris DeMuth's <a href=\"https://seekingalpha.com/article/1095761-gcvrz-a-potential-16-bagger-worth-the-risk\" target=\"_blank\">top ideas at the start of the year</a>. Including today's <font color=\"green\">near 5% gain</font>, they're ahead by about 10% since the article was published, but have significantly more upside, says DeMuth.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283572\" data-linked=\"Sanofi CVRs boosted by Lemtrada approval\" data-tweet=\"$SNY - Sanofi CVRs boosted by Lemtrada approval https://seekingalpha.com/news/1283572-sanofi-cvrs-boosted-by-lemtrada-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/1283572-sanofi-cvrs-boosted-by-lemtrada-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283542\" data-ts=\"1379426128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283542-grocery-store-stocks-frisky-after-safeway-poison-pill\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery store stocks frisky after Safeway poison pill</a></h4><ul> <li>Grocery store stocks are mild out-performers after Safeway <a href=\"https://seekingalpha.com/currents/post/128349\" target=\"_blank\">fires up</a> a poison pill to protect itself from an unwanted takeover.</li> <li>The group has fallen back in favor with some analysts after the perceived threat that food rivals Wal-Mart and Target would decimate store traffic faded a bit.</li> <li>Advancers: Kroger (NYSE:<a href=\"https://seekingalpha.com/symbol/KR\" title=\"Kroger Co.\">KR</a>) <font color=\"green\">+1.3%</font>, SuperValue <font color=\"green\">+0.5%</font>, Sprouts Farmers Market (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SFM\" title=\"Sprouts Farmers Market\">SFM</a>) <font color=\"green\">+1.1%</font>, Whole Foods Market (WFM) <font color=\"green\">+0.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283542\" data-linked=\"Grocery store stocks frisky after Safeway poison pill\" data-tweet=\"$KR $KR $SFM - Grocery store stocks frisky after Safeway poison pill https://seekingalpha.com/news/1283542-grocery-store-stocks-frisky-after-safeway-poison-pill?source=tweet\" data-url=\"https://seekingalpha.com/news/1283542-grocery-store-stocks-frisky-after-safeway-poison-pill\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283512\" data-ts=\"1379425496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283512-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul><li>3D Systems (<a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a> <font color='green'>+2.4%</font>) has been started at Outperform by Credit Suisse.</li><li>Broadcom (BRCM <font color='green'>+2.5%</font>) has been upgraded to Positive by Susquehanna.</li><li>Verizon (<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a> <font color='green'>+0.2%</font>) has been upgraded to Outperform by RBC.</li><li>InterActiveCorp (IACI <font color='red'>-1.3%</font>) has been cut to Sector Perform by RBC a week after Daily Beast editor-in-chief/co-founder Tina Brown <a href=\"https://seekingalpha.com/currents/post/1274732\" target=\"_blank\">announced her departure</a>.</li><li>Avago (<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='green'>+1.3%</font>) has been upgraded to Outperform by JMP.</li><li>Cavium (CAVM <font color='red'>-0.8%</font>) has been cut to Neutral by Lazard.</li></ul><div class=\"tiny-share-widget\" data-id=\"1283512\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$DDD $DDD $AVGO - A roundup of tech ratings changes https://seekingalpha.com/news/1283512-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1283512-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283502\" data-ts=\"1379425438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOS\" target=\"_blank\">MOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283502-fertilizer-makers-open-lower-after-mosaics-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fertilizer makers open lower after Mosaic&#39;s downside guidance</a></h4><ul>     <li>Fertilizer producers open lower - but perhaps not as much as feared - after Mosaic (<a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"red\">-1.4%</font>) <a href=\"https://seekingalpha.com/currents/post/1282262\" target=\"_blank\">cut its Q3 price and volume estimates</a> in its potash and phosphates businesses, citing caution from dealers in the short term that has resulted in deferred purchases.</li>     <li>Mosaic\u2019s previous financial forecast had been made just two weeks before  the breakup of the Russian potash marketing cartel; since then, \u201cinternational crop nutrient markets  have softened in part as a result of the distributors\u2019 cautiousness,\u201d the company says.</li>     <li>POT <font color=\"red\">-1.5%</font>, AGU <font color=\"red\">-0.5%</font>, <a href=\"https://seekingalpha.com/symbol/IPI\" title=\"Intrepid Potash, Inc.\">IPI</a> <font color=\"red\">-0.7%</font>, <a href=\"https://seekingalpha.com/symbol/CF\" title=\"CF Industries Holdings, Inc.\">CF</a> <font color=\"red\">-0.2%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/SOIL\" title=\"Global X Fertilizers/Potash ETF\">SOIL</a>, <a href=\"https://seekingalpha.com/symbol/MOO\" title=\"VanEck Vectors Agribusiness ETF\">MOO</a>, <a href=\"https://seekingalpha.com/symbol/CROP\" title=\"IQ Global Agribusiness Small Cap ETF\">CROP</a>, <a href=\"https://seekingalpha.com/symbol/PAGG\" title=\"Invesco Global Agriculture Portfolio ETF\">PAGG</a>, <a href=\"https://seekingalpha.com/symbol/VEGI\" title=\"iShares MSCI Global Agricultural Producers ETF\">VEGI</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283502\" data-linked=\"Fertilizer makers open lower after Mosaic&#39;s downside guidance\" data-tweet=\"$MOS $MOS $NTR - Fertilizer makers open lower after Mosaic&#39;s downside guidance https://seekingalpha.com/news/1283502-fertilizer-makers-open-lower-after-mosaics-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1283502-fertilizer-makers-open-lower-after-mosaics-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283472\" data-ts=\"1379424910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KYTH\" target=\"_blank\">KYTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283472-kythera-biopharmaceuticals-up-sharply-after-atxminus-101-data-goldman-cautious\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kythera Biopharmaceuticals up sharply after ATX-101 data, Goldman cautious</a></h4><ul>\n<li>Monday's <a href=\"https://seekingalpha.com/currents/post/1282502\" target=\"_blank\">AH rally</a> in shares of Kythera Biopharmaceuticals (<a href=\"https://seekingalpha.com/symbol/KYTH\" title=\"KYTHERA Biopharmaceuticals\">KYTH</a> <font color=\"green\">+26.3%</font>) looks set to carryover into today's regular session.<br>\n</li>\n<li>Leerink <a href=\"http://www.streetinsider.com/Analyst+Comments/Kythera+%28KYTH%29+Target+Raised+to+%2450+at+Leerink+Swann/8694647.html\" target=\"_blank\">sees a near 50% upside</a> from Monday's close after the company's submental fat treatment ATX-101 met its primary endpoints in two Phase 3 studies.</li>\n<li>\"We are ... introducing a blended DCF and comparable multiple price target of  $50/shr in the next 12 months, consistent with biotech's 56x multiple  on 2017E sales which we believe more fully reflects KYTH's strategic  value,\" analyst Seamus Fernandez says.</li>\n<li>As for Goldman \u2014 not so much. \"We think the product will ultimately gain approval and that it will end  up having a solid uptake commercially [but] our concern [is that] the high expectations ... are <a href=\"http://www.streetinsider.com/New+Coverage/Goldman+Sachs+Assumes+Kythera+Biopharmaceuticals+%28KYTH%29+at+Neutral/8694124.html\" target=\"_blank\">largely factored into</a> the [stock's] valuation,\" the firm notes, adding that \"<em>KYTH will probably use these data as a catalyst to raise more money</em>.\" (emphasis added)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283472\" data-linked=\"Kythera Biopharmaceuticals up sharply after ATX-101 data, Goldman cautious\" data-tweet=\"$KYTH - Kythera Biopharmaceuticals up sharply after ATX-101 data, Goldman cautious https://seekingalpha.com/news/1283472-kythera-biopharmaceuticals-up-sharply-after-atxminus-101-data-goldman-cautious?source=tweet\" data-url=\"https://seekingalpha.com/news/1283472-kythera-biopharmaceuticals-up-sharply-after-atxminus-101-data-goldman-cautious\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283442\" data-ts=\"1379424740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNX\" target=\"_blank\">MLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283442-ezchip-issues-statement-on-cisco-zte-concerns-shares-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EZchip issues statement on Cisco/ZTE concerns, shares rally</a></h4><ul>     <li>\"To the best of EZchip's (EZCH <font color=\"green\">+7.5%</font>) knowledge Cisco intends to use EZchip's NP-5 in all key platforms that use the NP-4 today, and Cisco has not yet made a decision on any NPU beyond NP-5 in those platforms.\" Those comments are in-line with a remark CEO Eli Fruchter <a href=\"https://seekingalpha.com/currents/post/1276092\" target=\"_blank\">made to Benchmark</a> in the wake of Cisco's nPower X1 announcement. (PR)</li>     <li>EZchip also once more talks up the potential of its NPS-400 processor (<a href=\"https://seekingalpha.com/currents/post/828931\" target=\"_blank\">previous</a>), declaring it will offer \"the highest integration and greatest power efficiency,\" of any NPU, as well as the most advanced traffic manager and the ability to \"support the greatest number of flows and subscribers.\" The NPS-400 is expected to start generating revenue in 2015.</li>     <li>Regarding ZTE, the company doesn't specifically deny <a href=\"https://seekingalpha.com/currents/post/1281642\" target=\"_blank\">Maxim's report</a> of a Broadcom design win, but does state ZTE plans to use the NP-5 \"as a follow on\" in platforms using the NP-3 and NP-4 to the best of its knowledge, and that the NP-5 \"is also in consideration for other [ZTE] platforms as are other NPUs from other vendors.\"</li>     <li>Shares still <font color=\"red\">-23%</font> from where they traded before Cisco's announcement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283442\" data-linked=\"EZchip issues statement on Cisco/ZTE concerns, shares rally\" data-tweet=\"$MLNX - EZchip issues statement on Cisco/ZTE concerns, shares rally https://seekingalpha.com/news/1283442-ezchip-issues-statement-on-cisco-zte-concerns-shares-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/1283442-ezchip-issues-statement-on-cisco-zte-concerns-shares-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283392\" data-ts=\"1379424311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283392-nucor-plus-2_2-percent-premarket-after-issuing-q3-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nucor +2.2% premarket after issuing Q3 guidance</a></h4><ul>     <li>Nucor (NYSE:<a href=\"https://seekingalpha.com/symbol/NUE\" title=\"Nucor Corporation\">NUE</a>) <font color=\"green\">+2.2%</font> premarket after issuing in-line guidance for Q3, seeing EPS of $0.35-$0.40 vs. $0.38 analyst consensus.</li>\n<li>Q3 results include an $18M LIFO credit ($0.03/share) vs. no LIFO charge and an $84M credit ($0.16/share) in Q2.</li>\n<li>Overall operating performance in the steel mills segment has improved  Q/Q, with stronger performance in  sheet and structural steel.</li>     <li>Says non-residential construction markets continue to lack sustained momentum but they are slowly improving from historically low levels; strongest end markets remain in manufactured goods including energy and automotive.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283392\" data-linked=\"Nucor +2.2% premarket after issuing Q3 guidance\" data-tweet=\"$NUE - Nucor +2.2% premarket after issuing Q3 guidance https://seekingalpha.com/news/1283392-nucor-plus-2_2-percent-premarket-after-issuing-q3-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1283392-nucor-plus-2_2-percent-premarket-after-issuing-q3-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283362\" data-ts=\"1379424044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283362-market-preview\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview</a></h4><ul>    <li>\n<a href=\"http://www.reuters.com/article/2013/09/17/us-markets-stocks-idUSBRE9890IQ20130917\" target=\"_blank\">U.S. stock futures</a> poke into the green after being slightly lower earlier and as the FOMC gathers for the first of a two-day policy meeting. However, European shares remain firmly in the red.</li>    <li>Dow <font color=\"green\">+0.1%</font>. S&amp;P <font color=\"green\">+0.04%</font>. Nasdaq <font color=\"green\">+0.15%</font>.</li>    <li>The Fed is expected to slice $10B from its $85B-a-month bond-buying scheme, a move that's been priced into the markets.</li>    <li>Rick Meckler of LibertyView Capital Management's believes the Fed's decision will \"leave the market relatively unchanged,\" at which point investors will start to focus onto company specific news.</li>    <li>\n<a href=\"https://seekingalpha.com/currents/post/1282532\" target=\"_blank\">Later</a>: NAHB Housing Market Index</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283362\" data-linked=\"Market preview\" data-tweet=\"Market preview https://seekingalpha.com/news/1283362-market-preview?source=tweet\" data-url=\"https://seekingalpha.com/news/1283362-market-preview\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283352\" data-ts=\"1379423770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283352-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"green\">+31%</font>. <a href=\"https://seekingalpha.com/symbol/KYTH\" title=\"KYTHERA Biopharmaceuticals\">KYTH</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/AGEN\" title=\"Agenus\">AGEN</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/ARO\" title=\"Aeropostale, Inc.\">ARO</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/HUN\" title=\"Huntsman Corporation\">HUN</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/CGEN\" title=\"Compugen Ltd.\">CGEN</a> <font color=\"green\">+7%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/OUTR\" title=\"Outerwall Inc.\">OUTR</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/GORO\" title=\"Gold Resource Corporation\">GORO</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/WERN\" title=\"Werner Enterprises, Inc.\">WERN</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/OCLR\" title=\"Oclaro, Inc.\">OCLR</a> <font color=\"red\">-8%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283352\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$RPRX $KYTH $AGEN - Premarket Gainers / Losers https://seekingalpha.com/news/1283352-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1283352-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283342\" data-ts=\"1379423698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WERN\" target=\"_blank\">WERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283342-werner-tumbles-pre-market-on-3-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Werner tumbles pre-market on 3 downgrades</a></h4><ul>     <li>Werner Enterprises (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WERN\" title=\"Werner Enterprises, Inc.\">WERN</a>) shares <font color=\"red\">tumble 6.8%</font> pre-market after RBC Capital <a href=\"http://www.streetinsider.com/rating_history.php?q=WERN\" target=\"_blank\">downgrades</a> the hauler to Perform, KeyBanc downgrades to Hold, and BofA to Neutral.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283342\" data-linked=\"Werner tumbles pre-market on 3 downgrades\" data-tweet=\"$WERN - Werner tumbles pre-market on 3 downgrades https://seekingalpha.com/news/1283342-werner-tumbles-pre-market-on-3-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/1283342-werner-tumbles-pre-market-on-3-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283292\" data-ts=\"1379423284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPLM\" target=\"_blank\">TPLM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283292-triangle-petroleum-to-expand-caliber-infrastructure-system\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Triangle Petroleum to expand Caliber infrastructure system</a></h4><ul>     <li>Triangle Petroleum (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/TPLM\" title=\"Triangle Petroleum Corporation\">TPLM</a>) <font color=\"green\">+2.2%</font> premarket on news it <a href=\"http://finance.yahoo.com/news/triangle-petroleum-announces-expansion-caliber-001900063.html\" target=\"_blank\">signed agreements</a> with joint venture partner First Reserve's Energy Infrastructure Fund to expand the Caliber Midstream Partners midstream and infrastructure system in North Dakota.</li>     <li>The expansion project includes a 50K bbl/day pipeline and 40K-barrel crude oil storage and related infrastructure, providing TPLM and other customers with access to multiple crude oil pipelines, rail terminals and market centers in the Williston Basin.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1283292\" data-linked=\"Triangle Petroleum to expand Caliber infrastructure system\" data-tweet=\"$TPLM - Triangle Petroleum to expand Caliber infrastructure system https://seekingalpha.com/news/1283292-triangle-petroleum-to-expand-caliber-infrastructure-system?source=tweet\" data-url=\"https://seekingalpha.com/news/1283292-triangle-petroleum-to-expand-caliber-infrastructure-system\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283282\" data-ts=\"1379423277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283282-tesla-motors-roundup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors roundup</a></h4><ul> <li>News that General Motors has <a href=\"https://seekingalpha.com/currents/post/1282772\" target=\"_blank\">big EV plans</a> only causes a minor ripple with shares of Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) in premarket action.</li> <li>Until GM's dreamy EV car goes from the drawing board to the showroom, industry execs think Tesla might keep a competitive advantage on driving range.</li> <li>\n<a href=\"https://twitter.com/thenotablecalls/status/379939518071062528\" target=\"_blank\">Analyst take</a>: Morgan Stanley says the Tesla story has years to play out. \"We find the inclination of many rational investors is to do nothing. We sort of agree.\"</li>\n<li>TSLA <font color=\"red\">-0.6%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283282\" data-linked=\"Tesla Motors roundup\" data-tweet=\"$TSLA - Tesla Motors roundup https://seekingalpha.com/news/1283282-tesla-motors-roundup?source=tweet\" data-url=\"https://seekingalpha.com/news/1283282-tesla-motors-roundup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283182\" data-ts=\"1379422577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGEN\" target=\"_blank\">AGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283182-agenus-rallies-on-phase-2-hsppcminus-96-brain-cancer-follow-on-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agenus rallies on Phase 2 HSPPC-96, brain cancer follow-on results</a></h4><ul>     <li>Agenus (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AGEN\" title=\"Agenus\">AGEN</a>) gets a welcome premarket lift from follow-on Phase 2 Prophage Series G-100 results in glioblastoma multiforme.</li>     <li>The company says Prophage Series G-100 in combination with radiation and temozolomide \"showed an       almost 18 month median PFS, which represents       a 160% increase versus current standard of care alone.\"</li>     <li>\n<em>There's quite a bit to go through in the PR</em>, but it seems like AGEN wants investors to get two things out of this release: 1) The follow-on data support the positive results reported back in May at AANS, and 2) the findings will be discussed with the FDA in relation to the initiation of a Phase 3 trial. (PR)</li>     <li>AGEN <font color=\"green\">+19%</font> premarket (a big help considering the <a href=\"https://seekingalpha.com/currents/post/1262742\" target=\"_blank\">beating the stock took</a> after the MAGE A-3 Phase 3 melanoma readout earlier this month).</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283182\" data-linked=\"Agenus rallies on Phase 2 HSPPC-96, brain cancer follow-on results\" data-tweet=\"$AGEN - Agenus rallies on Phase 2 HSPPC-96, brain cancer follow-on results https://seekingalpha.com/news/1283182-agenus-rallies-on-phase-2-hsppcminus-96-brain-cancer-follow-on-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1283182-agenus-rallies-on-phase-2-hsppcminus-96-brain-cancer-follow-on-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283162\" data-ts=\"1379422209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNDN\" target=\"_blank\">DNDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283162-dendreons-provenge-approved-in-europe-shares-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dendreon&#39;s Provenge approved in Europe, shares jump</a></h4><ul>     <li>The European Commission has granted Dendreon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a>) marketing authorization for its Provenge treatment for prostate cancer, with the approval also including Norway, Iceland and Liechtenstein.</li>     <li>It's a rare ray of sunshine for Dendreon, which seems to have few fans on Wall Street these days amid <a href=\"https://seekingalpha.com/currents/search?query=provenge\" target=\"_blank\">poor sales</a> for Provenge. In June, Wedbush analyst David Nierengarten predicted that even with EU approval, the drug has little chance of success.</li>     <li>Notwithstanding, shares are <font color=\"green\">+12.1%</font>. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283162\" data-linked=\"Dendreon&#39;s Provenge approved in Europe, shares jump\" data-tweet=\"$DNDN - Dendreon&#39;s Provenge approved in Europe, shares jump https://seekingalpha.com/news/1283162-dendreons-provenge-approved-in-europe-shares-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/1283162-dendreons-provenge-approved-in-europe-shares-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283032\" data-ts=\"1379421014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283032-repros-therapeutics-jumps-as-androxal-meets-endpoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Repros Therapeutics jumps as Androxal meets endpoints</a></h4><ul>     <li>Repros Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a>) soars <font color=\"green\">26%</font> premarket.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/search?query=androxal\" target=\"_blank\">Androxal</a> topline results from ZA-302 (pivotal efficacy) and ZA-300 (six-month safety) show the secondary  hypogonadism treatment <em>met both primary endpoints and is generally well tolerated</em>.</li>     <li>ZA-302 results are \"almost identical\" to the first pivotal efficacy study. (PR)</li>     <li>Expect an NDA in mid-2014.</li>     <li>RPRX says it expects to have \"launch drug product available for an anticipated approval during 2015.\"</li>     <li>It's worth noting that back in July, BofA's Steve Byrne said peak 2022 sales <a href=\"https://seekingalpha.com/currents/post/1117822\" target=\"_blank\">could reach</a> $450M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283032\" data-linked=\"Repros Therapeutics jumps as Androxal meets endpoints\" data-tweet=\"$RPRX - Repros Therapeutics jumps as Androxal meets endpoints https://seekingalpha.com/news/1283032-repros-therapeutics-jumps-as-androxal-meets-endpoints?source=tweet\" data-url=\"https://seekingalpha.com/news/1283032-repros-therapeutics-jumps-as-androxal-meets-endpoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1283012\" data-ts=\"1379420875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARO\" target=\"_blank\">ARO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1283012-aeropostale-soars-after-sycamore-partners-reveals-its-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeropostale soars after Sycamore Partners reveals its stake</a></h4><ul> <li>Sycamore Partners discloses holding a 7.96% position in Aeropostale (NYSE:<a href=\"https://seekingalpha.com/symbol/ARO\" title=\"Aeropostale, Inc.\">ARO</a>) after not holding any shares in the retailer at the end of Q2.</li> <li><a href=\"http://www.sec.gov/Archives/edgar/data/1168213/000110465913070300/a13-20797_1sc13d.htm\" target=\"_blank\">SEC Form 13D</a></li> <li>ARO <font color=\"green\">+12.7%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1283012\" data-linked=\"Aeropostale soars after Sycamore Partners reveals its stake\" data-tweet=\"$ARO - Aeropostale soars after Sycamore Partners reveals its stake https://seekingalpha.com/news/1283012-aeropostale-soars-after-sycamore-partners-reveals-its-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/1283012-aeropostale-soars-after-sycamore-partners-reveals-its-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1282952\" data-ts=\"1379419930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOHU\" target=\"_blank\">SOHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1282952-goldman-makes-sohu-a-conviction-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman makes Sohu a Conviction Buy</a></h4><ul>     <li>\n<a href=\"https://seekingalpha.com/symbol/SOHU\" title=\"Sohu.com Limited\">SOHU</a> <font color=\"green\">gains another 2.6%</font> premarket after <a href=\"http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Sohu+%28SOHU%29+to+Conviction+Buy/8694378.html\" target=\"_blank\">Goldman Sachs puts the name</a> on its Conviction Buy list with $98 per share price target, a modest 40% above yesterday's close. Costly investments in video, search, and mobile are about to pay off in the form of accelerating earnings, says Goldman.</li>     <li>Sohu <font color=\"green\">flew 7.5%</font> yesterday following<a href=\"https://seekingalpha.com/currents/post/1280552\" target=\"_blank\"> its deal</a> with Tencent.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1282952\" data-linked=\"Goldman makes Sohu a Conviction Buy\" data-tweet=\"$SOHU - Goldman makes Sohu a Conviction Buy https://seekingalpha.com/news/1282952-goldman-makes-sohu-a-conviction-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1282952-goldman-makes-sohu-a-conviction-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1282662\" data-ts=\"1379410287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1282662-global-stocks-fall-ahead-of-fomc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global stocks fall ahead of FOMC</a></h4><ul>     <li>\n<a href=\"http://www.reuters.com/article/2013/09/17/markets-global-idUSL5N0HD0XI20130917\" target=\"_blank\">Global equities</a> mostly drop prior to the start of the FOMC's two-day meeting today, when the Fed is expected to reduce its bond-buying program by $10B a month to $75B despite a tepid jobs report for August.</li>     <li>\"Investors are pricing in $10B, but $20B or above could create waves, so people remain cautious ahead of the decision,\" says Global Equities' David Thebault.</li>     <li>\n<a href=\"http://www.bloomberg.com/news/2013-09-17/china-stock-index-futures-fall-before-foreign-investment-data.html\" target=\"_blank\">China</a> <font color=\"red\">falls 2%</font> following a sharp slowdown in foreign direct investment and a rise in money market rates.</li>     <li>Japan <font color=\"red\">-0.7%</font>, Hong Kong <font color=\"red\">-0.3%</font>, India <font color=\"green\">+0.1%</font>.</li>     <li>EU Stoxx 50 <font color=\"red\">-0.3%</font>, London <font color=\"red\">-0.3%</font>, Paris <font color=\"red\">-0.4%</font>, Frankfurt <font color=\"red\">-0.2%</font>, Milan <font color=\"red\">-0.4%</font>, Madrid <font color=\"red\">-0.7%</font>.  U.S. stock futures: Dow <font color=\"red\">-0.1%</font>, S&amp;P <font color=\"red\">-0.1%</font>, Nasdaq <font color=\"red\">-0.05%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/ezu\" title=\"iShares MSCI EMU ETF\">EZU</a>, <a href=\"https://seekingalpha.com/symbol/vgk\" title=\"Vanguard FTSE Europe ETF\">VGK</a>, <a href=\"https://seekingalpha.com/symbol/fez\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>, <a href=\"https://seekingalpha.com/symbol/epv\" title=\"ProShares UltraShort Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/iev\" title=\"iShares Europe ETF\">IEV</a>,  <a href=\"https://seekingalpha.com/symbol/adru\" title=\"BLDRS Europe 100 ADR Index ETF\">ADRU</a>, <a href=\"https://seekingalpha.com/symbol/fep\" title=\"First Trust Europe AlphaDEX ETF\">FEP</a>, <a href=\"https://seekingalpha.com/symbol/fdd\" title=\"First Trust Dow Jones STOXX European Select Dividend 30 Index ETF\">FDD</a>, <a href=\"https://seekingalpha.com/symbol/upv\" title=\"ProShares Ultra Europe ETF\">UPV</a>, <a href=\"https://seekingalpha.com/symbol/epv\" title=\"ProShares UltraShort Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/dfe\" title=\"WisdomTree Europe SmallCap Dividend ETF\">DFE</a>, <a href=\"https://seekingalpha.com/symbol/feu\" title=\"SPDR STOXX Europe 50 ETF\">FEU</a>, <a href=\"https://seekingalpha.com/symbol/feeu\" title=\"Barclays ETN+ FI Enhanced Europe 50 ETN\">FEEU</a>, <a href=\"https://seekingalpha.com/symbol/fxi\" title=\"iShares China Large-Cap ETF\">FXI</a>, <a href=\"https://seekingalpha.com/symbol/gxc\" title=\"SPDR S&amp;P China ETF\">GXC</a>, <a href=\"https://seekingalpha.com/symbol/pgj\" title=\"PowerShares Golden Dragon China Portfolio ETF\">PGJ</a>, <a href=\"https://seekingalpha.com/symbol/yao\" title=\"Guggenheim China All-Cap ETF \">YAO</a>, <a href=\"https://seekingalpha.com/symbol/fchi\" title=\"iShares FTSE China (HK-Listed) Index ETF\">FCHI</a>, <a href=\"https://seekingalpha.com/symbol/pek\" title=\"Market Vectors China ETF \">PEK</a>, <a href=\"https://seekingalpha.com/symbol/caf\" title=\"Morgan Stanley China A Share Fund\">CAF</a>, <a href=\"https://seekingalpha.com/symbol/yxi\" title=\"ProShares Short FTSE China 25 ETF\">YXI</a>, <a href=\"https://seekingalpha.com/symbol/xpp\" title=\"ProShares Ultra FTSE China 25 ETF\">XPP</a>, <a href=\"https://seekingalpha.com/symbol/fxp\" title=\"ProShares UltraShort FTSE China 25 ETF\">FXP</a>, <a href=\"https://seekingalpha.com/symbol/mchi\" title=\"iShares MSCI China ETF\">MCHI</a>, <a href=\"https://seekingalpha.com/symbol/yinn\" title=\"Direxion Daily China Bull 3x Shares ETF\">YINN</a>, <a href=\"https://seekingalpha.com/symbol/yang\" title=\"Direxion Daily China Bear 3x Shares ETF\">YANG</a>, <a href=\"https://seekingalpha.com/symbol/tchi\" title=\"RBS China Trendpilot ETN\">TCHI</a>, <a href=\"https://seekingalpha.com/symbol/chxf\" title=\"WisdomTree China Dividend ex-Financials ETF\">CHXF</a>, <a href=\"https://seekingalpha.com/symbol/kfyp\" title=\"KraneShares CSI China Five Year Plan ETF\">KFYP</a>, <a href=\"https://seekingalpha.com/symbol/hao\" title=\"Guggenheim China Small Cap ETF \">HAO</a>, <a href=\"https://seekingalpha.com/symbol/ecns\" title=\"iShares MSCI China Small-Cap ETF\">ECNS</a>, <a href=\"https://seekingalpha.com/symbol/adra\" title=\"BLDRS Asia 50 ADR Index ETF\">ADRA</a>, <a href=\"https://seekingalpha.com/symbol/aia\" title=\"iShares Asia 50 ETF\">AIA</a>, <a href=\"https://seekingalpha.com/symbol/vpl\" title=\"Vanguard FTSE Pacific ETF\">VPL</a>, <a href=\"https://seekingalpha.com/symbol/asdr\" title=\"VelocityShares Emerging Asia Depositary Receipt ETF\">ASDR</a>, <a href=\"https://seekingalpha.com/symbol/aaxj\" title=\"iShares MSCI All Country Asia ex-Japan Index ETF\">AAXJ</a>, <a href=\"https://seekingalpha.com/symbol/axjs\" title=\"iShares MSCI All Country Asia ex-Japan Small Cap Index ETF\">AXJS</a>, <a href=\"https://seekingalpha.com/symbol/epp\" title=\"iShares MSCI Pacific ex Japan ETF\">EPP</a>, <a href=\"https://seekingalpha.com/symbol/gmf\" title=\"SPDR S&amp;P Emerging Asia Pacific ETF\">GMF</a>, <a href=\"https://seekingalpha.com/symbol/gmfs\" title=\"SPDR S&amp;P Small Cap Emerging Asia Pacific ETF\">GMFS</a>, <a href=\"https://seekingalpha.com/symbol/axjl\" title=\"WisdomTree Asia-Pacific ex-Japan ETF\">AXJL</a>, <a href=\"https://seekingalpha.com/symbol/uxj\" title=\"ProShares Ultra MSCI Pacific Ex-Japan ETF\">UXJ</a>, <a href=\"https://seekingalpha.com/symbol/jpx\" title=\"ProShares UltraShort MSCI Pacific ex-Japan ETF\">JPX</a>, <a href=\"https://seekingalpha.com/symbol/paf\" title=\"PowerShares FTSE RAFI Asia Pacific ex-Japan Portfolio ETF\">PAF</a>, <a href=\"https://seekingalpha.com/symbol/asea\" title=\"Global X FTSE ASEAN 40 ETF\">ASEA</a>, <a href=\"https://seekingalpha.com/symbol/eema\" title=\"iShares MSCI Emerging Markets Asia Index ETF\">EEMA</a>, <a href=\"https://seekingalpha.com/symbol/dvya\" title=\"iShares Asia/Pacific Dividend ETF\">DVYA</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1282662\" data-linked=\"Global stocks fall ahead of FOMC\" data-tweet=\"$EZU $VGK $FEZ - Global stocks fall ahead of FOMC https://seekingalpha.com/news/1282662-global-stocks-fall-ahead-of-fomc?source=tweet\" data-url=\"https://seekingalpha.com/news/1282662-global-stocks-fall-ahead-of-fomc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 AM </div></div></li>","count":49,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}